62Cu ETS - Proportional Technologies

Drug Profile

62Cu ETS - Proportional Technologies

Alternative Names: (62)Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II) - Proportional Technologies

Latest Information Update: 24 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Proportional Technologies
  • Class Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer; Renal failure

Most Recent Events

  • 28 Feb 2017 Discontinued - Phase-II for Renal failure (Diagnosis) in USA (IV) (NCT00714142)
  • 30 Aug 2016 Discontinued - Clinical-Phase-Unknown for Cancer (Diagnosis) in USA (IV)
  • 30 Aug 2016 Discontinued - Clinical-Phase-Unknown for Cancer (Diagnosis, In volunteers) in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top